These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 28770558)
1. Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma. Handa H; Kuroda Y; Kimura K; Masuda Y; Hattori H; Alkebsi L; Matsumoto M; Kasamatsu T; Kobayashi N; Tahara KI; Takizawa M; Koiso H; Ishizaki T; Shimizu H; Yokohama A; Tsukamoto N; Saito T; Murakami H Br J Haematol; 2017 Nov; 179(3):449-460. PubMed ID: 28770558 [TBL] [Abstract][Full Text] [Related]
2. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863 [TBL] [Abstract][Full Text] [Related]
3. Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Hu Y; Lin J; Fang H; Fang J; Li C; Chen W; Liu S; Ondrejka S; Gong Z; Reu F; Maciejewski J; Yi Q; Zhao JJ Leukemia; 2018 Oct; 32(10):2250-2262. PubMed ID: 29632340 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma. Liu H; Wang H; Wu B; Yao K; Liao A; Miao M; Li Y; Yang W Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1032-1041. PubMed ID: 28664617 [TBL] [Abstract][Full Text] [Related]
6. Focusing on long non-coding RNA dysregulation in newly diagnosed multiple myeloma. Shen Y; Feng Y; Chen H; Huang L; Wang F; Bai J; Yang Y; Wang J; Zhao W; Jia Y; Peng Y; Lei X; He A Life Sci; 2018 Mar; 196():133-142. PubMed ID: 29459023 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Pang EJ; Yang R; Fu XB; Liu YF Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma. Chu YH; Hardin H; Schneider DF; Chen H; Lloyd RV Exp Mol Pathol; 2017 Oct; 103(2):229-236. PubMed ID: 29107050 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis. Zhang C; Chu M; Fan Y; Wu L; Li Z; Ma X; Zhuang W J Clin Lab Anal; 2020 Sep; 34(9):e23400. PubMed ID: 32578294 [TBL] [Abstract][Full Text] [Related]
11. Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development. Jin C; Yan B; Lu Q; Lin Y; Ma L Tumour Biol; 2016 Jun; 37(6):7383-94. PubMed ID: 26676637 [TBL] [Abstract][Full Text] [Related]
12. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. Li B; Chen P; Qu J; Shi L; Zhuang W; Fu J; Li J; Zhang X; Sun Y; Zhuang W J Biol Chem; 2014 Oct; 289(42):29365-75. PubMed ID: 25187517 [TBL] [Abstract][Full Text] [Related]
14. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma. Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma. Wong KY; Li Z; Zhang X; Leung GK; Chan GC; Chim CS Mol Cancer; 2015 Sep; 14():175. PubMed ID: 26410378 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
17. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
18. EWSR1 overexpression is a pro-oncogenic event in multiple myeloma. Nishiyama D; Chinen Y; Isa R; Fujibayashi Y; Kuwahara-Ota S; Yamaguchi J; Takimoto-Shimomura T; Matsumura-Kimoto Y; Tsukamoto T; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Handa H; Kuroda J Int J Hematol; 2021 Mar; 113(3):381-394. PubMed ID: 33095415 [TBL] [Abstract][Full Text] [Related]
19. Long Non Coding RNA MALAT1 Promotes Tumor Growth and Metastasis by inducing Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. Zhou X; Liu S; Cai G; Kong L; Zhang T; Ren Y; Wu Y; Mei M; Zhang L; Wang X Sci Rep; 2015 Nov; 5():15972. PubMed ID: 26522444 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance. Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]